Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 1.44 Billion | USD 10.97 Billion | 25.3% | 2024 |
The global artificial intelligence in diabetes management market size was worth around USD 1.44 Billion in 2024 and is predicted to grow to around USD 10.97 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 25.3% between 2025 and 2034.
The report analyzes the global artificial intelligence in diabetes management market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the artificial intelligence in diabetes management industry.
Artificial intelligence and machine learning have incredibly expanded the potential in the field of diabetes care. The AI-based management techniques in the field of diabetes mellitus are transforming rapidly with a goal to lower the prevalence of cases associated with diabetes 1 and 2. However, the application of artificial intelligence-based technology, particularly in self-managing diabetes, is crucial for enhancing the quality of life, boosting metabolic control, and for timely intervention for the patient population. Additionally, data-driven decisions help better manage diabetes.
Growing diabetes cases will drive the growth of the global market
The growing cases of diabetes all around the globe is one of the primary reasons fueling the growth of global artificial intelligence in the diabetes management market. However, such an increasing rate of diabetes can be attributed to the sedentary lifestyle of people and rapid urbanization globally. Additionally, the growing funding from private and government organizations is fueling the research and development activities to develop advanced solutions in diabetes management will further boost the growth rate.
Artificial intelligent applications have vast clinical potential in preventing diabetes and educating people regarding their lifestyle. It also guides users regarding their exercise regime, dietary habits, and insulin injection schedules. The growing morbidity and mortality cases in several regions due to diabetes are fostering the large-scale adoption of artificial intelligence in diabetes management.
Lack of awareness among people is likely to restrain the growth of the global market.
Consumers are not aware of the innovative solutions available in the market for managing diabetes effectively. Additionally, many diabetes patients do not prefer monitoring their diabetes frequently, which is also likely to hamper the growth of the market.
Advancements in the field of artificial intelligence are likely to create new avenues in the global market.
The ongoing innovation and development activities in the field of artificial intelligence are likely to create new lucrative growth opportunities in the global artificial intelligence in the diabetes management market. Also, the integration of advanced technology with healthcare facilities will further expand the potential of the global market.
Need for high investment is a huge challenge in the global market.
Research activities and clinical trials require high investments, which limits the scope of the global market. On the other hand, the end products are also expensive. Therefore, not many consumers are willing to go with smart solutions for diabetes management.
The global artificial intelligence in diabetes management market is segmented based on Technique, Device, and region.
Based on Technique, the global artificial intelligence in diabetes management market is divided into Intelligent Data Analysis And Case-Based Reasoning.
On the basis of Device, the global artificial intelligence in diabetes management market is bifurcated into Insulin Delivery Devices, Glucose Monitoring Devices, And Diagnostic Devices.
Report Attributes | Report Details |
---|---|
Report Name | Artificial Intelligence in Diabetes Management Market |
Market Size in 2024 | USD 1.44 Billion |
Market Forecast in 2034 | USD 10.97 Billion |
Growth Rate | CAGR of 25.3% |
Number of Pages | 160 |
Key Companies Covered | Vodafone Group Plc, Tidepool, IBM Corporation, Google Inc., Glooko Inc., Diabnext, and Apple Inc, and others. |
Segments Covered | By Technique, By Device, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, The Middle East and Africa (MEA) |
Base Year | 2024 |
Historical Year | 2020 to 2023 |
Forecast Year | 2025 - 2034 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America holds the largest share of the global market.
North America accounts for the largest share of the global artificial intelligence in the diabetes management market due to the ongoing innovations in artificial intelligence-based services. Also, the growing awareness among consumers regarding the availability of smart devices for managing diabetes will further contribute to the growth of the regional market.
However, the region is in the next stage of digitalization, and therefore, concepts like robotics, machine learning, big data, artificial intelligence, and the Internet of Things are expanding rapidly in different fields. Prominent market players are launching innovative products in the market to expand the market base, which is likely to further develop the regional market.
Asia Pacific to emerge as the fastest-growing region in the global market.
Asia Pacific is likely to grow significantly in the forthcoming years due to the presence of a large diabetes population base in the region.
The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the artificial intelligence in diabetes management market on a global and regional basis.
The global artificial intelligence in diabetes management market is dominated by players like:
The global artificial intelligence in diabetes management market is segmented as follows;
By Technique
By Device
By Region
FrequentlyAsked Questions
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed